Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | Visfatin | 1 | ng/mL | 1 | IL-15 | 71.0 | 41 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 81.0 | 74 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 94.0 | 47 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 89.0 | 59 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 65.5 | 42 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 73.0 | 55 | |
| N2586 | Visfatin | 1 | ng/mL | 1 | IL-15 | 68.0 | 49 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 93.0 | 67 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 93.0 | 60 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 73.0 | 75 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 67.0 | 49 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-15 | 76.0 | 26 | |
| 0 | IL-15 | 63.0 | 50 | ||||||||
| RA2159 | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 100.0 | 47 | ||||
| RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 111.0 | 47 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 99.5 | 44 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 85.0 | 38 | |
| RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 83.5 | 58 | |
| RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 73.5 | 62 | |
| N2586 | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 94.5 | 48 | ||||
| N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 93.5 | 60 | |
| N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 70.0 | 49 | |
| N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 76.5 | 30 | |
| N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 110.0 | 52 | |
| N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-15 | 86.0 | 42 |